Modulation of orbitofrontal response to amphetamine by a functional variant of DAT1 and in vitro confirmation

Molecular Psychiatry

Volumn 16, Issue 2, 2011, Pages 124-126

  Brotons, O ^a,b   O'Daly, O G ^c   Guindalini, C ^c,d,e   Howard, M ^f   Bubb, J ^f   Barker, G ^c   Dalton, J ^c   Quinn, J ^f   Murray, R M ^c   Breen, G ^c,g   Shergill, S S ^a,c  

^a University Hospital Clinic   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g King s College London   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DNA; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; PLACEBO; UNCLASSIFIED DRUG;

ALLELE; CONTROLLED STUDY; DRUG RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; IN VITRO STUDY; LETTER; NEUROMODULATION; ORBITAL CORTEX; PRIORITY JOURNAL; REWARD; TASK PERFORMANCE; VARIABLE NUMBER OF TANDEM REPEAT;

AMPHETAMINE; DECISION MAKING; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; GAMES, EXPERIMENTAL; GENOTYPE; HUMANS; HYPERKINESIS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MINISATELLITE REPEATS; OXYGEN; PREFRONTAL CORTEX; REWARD;

EID: 79151481125     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2009.6     Document Type: Letter

References (10)

1. Zahniser NR, Sorkin A. Neuropharmacology 2004; 47: 80-91.
2. Guindalini C, Howard M, Larajeira R, Collier D, Ammar N, Craig I et al. Proc Natl Acad Sci USA 2006; 103: 4552-4557.
3. Volkow ND. J Nucl Med 2004; 45: 13N-16N, 19N-20N, 22N passim.
4. Schoenbaum G, Roesch MR, Stalnaker TA. Trends Neurosci 2006; 29: 116-124.
5. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Nature 1996; 379: 606-612.
6. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K et al. Am J Psychiatry 2003; 160: 1699-1701.
7. Volkow ND, Chang L,Wang GL, Fowler JS, Ding YS, Sedler Met al. Am J Psychiatry 2001; 158: 2015-2021.
8. Volkow ND,Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A et al. Am J Psychiatry 1999; 156: 1440-1443.
9. Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Ding YS et al. J Neurosci 2005; 25: 3932-3939.
10. Bellgrove MA, Chambers CD, Johnson KA, Daibhis A, Daly M, Hawi Z et al. Mol Psychiatry 2007; 12: 786-792.